Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes
dc.contributor.author | Boldison, J | |
dc.contributor.author | Long, AE | |
dc.contributor.author | Aitken, RJ | |
dc.contributor.author | Wilson, IV | |
dc.contributor.author | Megson, C | |
dc.contributor.author | Hanna, SJ | |
dc.contributor.author | Wong, FS | |
dc.contributor.author | Gillespie, KM | |
dc.date.accessioned | 2021-11-10T10:33:14Z | |
dc.date.issued | 2021-10-28 | |
dc.date.updated | 2021-11-09T11:07:47Z | |
dc.description.abstract | Aims/hypothesis Slow progressors to type 1 diabetes are individuals positive for multiple pancreatic islet autoantibodies who have remained diabetes-free for at least 10 years; regulation of the autoimmune response is understudied in this group. Here, we profile CD4+ regulatory T cells (Tregs) in a small but well-characterised cohort of extreme slow progressors with a median age 43 (range 31–72 years), followed up for 18–32 years. Methods Peripheral blood samples were obtained from slow progressors (n = 8), age- and sex-matched to healthy donors. One participant in this study was identified with a raised HbA1c at the time of assessment and subsequently diagnosed with diabetes; this donor was individually evaluated in the analysis of the data. Peripheral blood mononuclear cells (PBMCs) were isolated, and to assess frequency, phenotype and function of Tregs in donors, multi-parameter flow cytometry and T cell suppression assays were performed. Unsupervised clustering analysis, using FlowSOM and CITRUS (cluster identification, characterization, and regression), was used to evaluate Treg phenotypes. Results Unsupervised clustering on memory CD4+ T cells from slow progressors showed an increased frequency of activated memory CD4+ Tregs, associated with increased expression of glucocorticoid-induced TNFR-related protein (GITR), compared with matched healthy donors. One participant with a raised HbA1c at the time of assessment had a different Treg profile compared with both slow progressors and matched controls. Functional assays demonstrated that Treg-mediated suppression of CD4+ effector T cells from slow progressors was significantly impaired, compared with healthy donors. However, effector CD4+ T cells from slow progressors were more responsive to Treg suppression compared with healthy donors, demonstrated by increased suppression of CD25 and CD134 expression on effector CD4+ T cells. Conclusions/interpretations We conclude that activated memory CD4+ Tregs from slow progressors are expanded and enriched for GITR expression, highlighting the need for further study of Treg heterogeneity in individuals at risk of developing type 1 diabetes. | en_GB |
dc.description.sponsorship | Diabetes UK | en_GB |
dc.description.sponsorship | JDRF | en_GB |
dc.identifier.citation | Published onlin 28 October 2021 | en_GB |
dc.identifier.doi | https://doi.org/10.1007/s00125-021-05595-0 | |
dc.identifier.grantnumber | 14/0004869 | en_GB |
dc.identifier.grantnumber | 17–2013-529 | en_GB |
dc.identifier.grantnumber | 18/0005778 | en_GB |
dc.identifier.grantnumber | 3-APF-2018-591-A-N | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/127738 | |
dc.identifier | ORCID: 0000-0002-9146-5692 (Boldison, Joanne) | |
dc.language.iso | en | en_GB |
dc.publisher | Springer | en_GB |
dc.rights | © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | en_GB |
dc.subject | Autoantibodies | en_GB |
dc.subject | Slow progression | en_GB |
dc.subject | Type 1 diabetes | en_GB |
dc.subject | Regulatory T cells | en_GB |
dc.subject | CD4+ T cells | en_GB |
dc.title | Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2021-11-10T10:33:14Z | |
dc.identifier.issn | 0012-186X | |
dc.description | This is the final version. Available on open access from Springer via the DOI in this record | en_GB |
dc.description | Data availability: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request. | en_GB |
dc.identifier.eissn | 1432-0428 | |
dc.identifier.journal | Diabetologia | en_GB |
dc.relation.ispartof | Diabetologia | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2021-08-26 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2021-10-28 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2021-11-10T10:30:52Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2021-11-10T10:33:25Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2021-10-28 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.